Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a

NCT03320265 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated

Conditions

Arterial Inflammation
Cardiovascular Diseases

Interventions

DRUG: PC-mAb
DRUG: Placebo

Sponsor

Athera Biotechnologies AB